AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 135 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $39,655 | -28.2% | 28,529 | +2.7% | 0.00% | -100.0% |
| Q4 2022 | $55,262 | +2.3% | 27,770 | +4.2% | 0.00% | 0.0% |
| Q3 2022 | $54,000 | -35.7% | 26,638 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $84,000 | -22.9% | 26,312 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $109,000 | -12.8% | 26,245 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $125,000 | -11.3% | 26,115 | -0.8% | 0.00% | 0.0% |
| Q3 2021 | $141,000 | +5.2% | 26,332 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $134,000 | -28.7% | 26,084 | -6.6% | 0.00% | -50.0% |
| Q1 2021 | $188,000 | +48.0% | 27,934 | +0.5% | 0.00% | +100.0% |
| Q4 2020 | $127,000 | +13.4% | 27,803 | -3.8% | 0.00% | 0.0% |
| Q3 2020 | $112,000 | +19.1% | 28,892 | +46.9% | 0.00% | 0.0% |
| Q2 2020 | $94,000 | +6.8% | 19,673 | -21.9% | 0.00% | -50.0% |
| Q1 2020 | $88,000 | – | 25,185 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
| Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
| TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
| Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
| Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
| Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
| Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
| Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
| Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
| EAM Investors, LLC | 230,271 | $971,744 | 0.19% |